[PP1-17,Ala31,Aib32]NPY (human)



[PP1-17,Ala31,Aib32]NPY (human)

A1AA1P2PP2L3LL3E4EE4P5PP5V6VV6Y7YY7P8PP8G9GG9D10DD10N11NN11A12AA12T13TT13P14PP14E15EE15Q16QQ16M17MM17A18AA18R19RR19Y20YY20Y21YY21S22SS22A23AA23L24LL24R25RR25H26HH26Y27YY27I28II28N29NN29L30LL30A31AA31X32XX32R33RR33Q34QQ34R35RR35Y36YY36

SMILES None
InChIKey None
Sequence APLEPVYPGDNATPEQMARYYSALRHYINLAXRQRY

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

[PP1-17,Ala31,Aib32]NPY (human)

A1AA1P2PP2L3LL3E4EE4P5PP5V6VV6Y7YY7P8PP8G9GG9D10DD10N11NN11A12AA12T13TT13P14PP14E15EE15Q16QQ16M17MM17A18AA18R19RR19Y20YY20Y21YY21S22SS22A23AA23L24LL24R25RR25H26HH26Y27YY27I28II28N29NN29L30LL30A31AA31X32XX32R33RR33Q34QQ34R35RR35Y36YY36

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.